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Abstract
Background: Gene silencing using exogenous small interfering RNAs (siRNAs) is now a widespread molecular tool for 
gene functional study and new-drug target identification. The key mechanism in this technique is to design efficient 
siRNAs that incorporated into the RNA-induced silencing complexes (RISC) to bind and interact with the mRNA targets 
to repress their translations to proteins. Although considerable progress has been made in the computational analysis 
of siRNA binding efficacy, few joint analysis of different RNAi experiments conducted under different experimental 
scenarios has been done in research so far, while the joint analysis is an important issue in cross-platform siRNA efficacy 
prediction. A collective analysis of RNAi mechanisms for different datasets and experimental conditions can often 
provide new clues on the design of potent siRNAs.
Results: An elegant multi-task learning paradigm for cross-platform siRNA efficacy prediction is proposed. 
Experimental studies were performed on a large dataset of siRNA sequences which encompass several RNAi 
experiments recently conducted by different research groups. By using our multi-task learning method, the synergy 
among different experiments is exploited and an efficient multi-task predictor for siRNA efficacy prediction is obtained. 
The 19 most popular biological features for siRNA according to their jointly importance in multi-task learning were 
ranked. Furthermore, the hypothesis is validated out that the siRNA binding efficacy on different messenger 
RNAs(mRNAs) have different conditional distribution, thus the multi-task learning can be conducted by viewing tasks 
at an "mRNA"-level rather than at the "experiment"-level. Such distribution diversity derived from siRNAs bound to 
different mRNAs help indicate that the properties of target mRNA have important implications on the siRNA binding 
efficacy.
Conclusions: The knowledge gained from our study provides useful insights on how to analyze various cross-platform 
RNAi data for uncovering of their complex mechanism.
Background
RNA interference (RNAi) is the process through which a
double-stranded RNA (dsRNA) induces gene expression
silencing, by either degradation of sequence-specific
complementary mRNA or repression of translation [1].
Nowadays, RNAi has become an effective tool to inhibit
gene expression, serving as a potential therapeutic strat-
egy in viral diseases, drug target discovery and cancer
therapy [2]. The key inhibition mechanism of RNAi is
triggered by introducing a short interfering double-
stranded RNA (siRNA,19~ 27 bp) into the cytoplasm,
where the guide strand of siRNA (usually antisense
strand) is incorporated into the RNA-induced silencing
complex (RISC) that binds to its target mRNA and the
expression of the target gene is blocked. How to design
siRNAs with high efficacy and high specificity for their
target genes is one of the critical research issues [3-7].
So far, considerable progress has been made in studying
the silencing capacity of siRNAs (the siRNA binding effi-
cacy). Some fundamental empirical guidelines for design-
ing efficient siRNA molecules have been presented [8,9].
Further investigations include the study of the RNAi
mechanism itself as well as characteristics of siRNAs with
either high or low silencing capacity [10-16]. In total,
these studies have led to several advanced algorithms and
tools that allow the selection of potent siRNAs or the pre-
diction of the efficacy of siRNA for gene silencing [13,17-
26].
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Computational models for siRNA efficacy prediction
are often constructed in a training phase. The training
data consist of a collection siRNA sequences and related
inhibiting efficacy vis-a-vis their target genes. In the test-
ing phase, trained models are applied to new instances,
when potential characteristics related to siRNA efficacy
are extracted from siRNA sequences or target mRNA and
used for the prediction of siRNAs efficacy for new tar-
gets. This procedure is generally formulated as a classifi-
cation or regression model [24]. Although various
statistical and machine learning methods have been pro-
posed in the last few years [24,27,28], there is limited suc-
cess in predicting siRNA efficacy due to the diversity of
data and limited sizes of available siRNA datasets. The
problem caused by the differences in the training data
pose difficulties for in-silico siRNA design. Typically, the
RNAi data are provided by different research groups
under different platforms/protocols in different experi-
mental scenarios. This kind of data is refereed as "cross-
platform" to emphasize the considerable diversity in such
data. We observed that usually the observations (siRNA
efficacy) from multiple platforms may not have an identi-
cal conditional distribution (i.e. the same residual vari-
ance) due to: First, a variety of assays/platforms/scales
exist for measurements of the siRNA efficacy, such as dif-
ferent cell types (Hela, fibroblasts), test methods (West-
ern Blotting, real-time PCR) or siRNA delivery methods
(vectors method, synthetic oligos method). Second, there
may exist very different concentrations of siRNAs used in
different experiments. Finally, large differences can be
found in sub-optimal time intervals between transfection
and down-regulation measurement etc [24,29].
As we show later in the experimental part, a naive inte-
gration of the data for siRNA efficacy prediction will only
result in poor performance. This data distribution diver-
sity problem has largely been ignored in many previous
studies, such as the P?l Sætrom data [24], a classical data-
set for siRNA efficacy prediction. This dataset has been
used as a benchmark for training and testing in several
computational studies for siRNA efficacy prediction, but
the issue of non-identical conditional distribution has not
received sufficient attention [30,31].
Since different RNAi experiments encompass siRNAs
that are partially targeted on different mRNAs, how to
jointly utilize different experimental datasets becomes a
critical issue for large-scale RNAi screening analysis.
Solutions to this problem are expected to provide new
insights into the RNAi mechanism in a large-scale view.
In our study, although cross-platform siRNA datasets
may have different conditional distribution of their effi-
cacy, they are related to a common biological problem
and can be viewed as different prediction tasks under the
s a m e  l a t e n t  v a r i a b l e s .  T h i s  o b s e r v a t i o n  i n s p i r e s  u s  t o
exploit the possible synergies between different datasets,
rather than combining them directly, to learn a multi-task
predictor jointly and simultaneously for siRNA efficacy
prediction. This predictor will allow different classifica-
tion tasks to enhance each other during the training pro-
cess, which eventually makes the efficacy prediction
better than when the datasets are naively combined, or
when the datasets are used separately.
In this paper, the cross-platform model construction
issue was addressed by applying a simple, yet effective lin-
ear regression model based on the multi-task learning
paradigm. This model was applied on multiple datasets
for siRNA efficacy prediction. Recently, [32] presented a
multi-task learning approach to learning drug combina-
tions for drug design. In [33], a multi-task classification
approach is applied on multiple platforms for finding out
a small number of highly significant marker genes to aid
in biological studies, where the emphasis is on feature
selection across platforms. In [34], a novel transfer learn-
ing technique is applied to address such cross-platform
siRNA efficacy prediction problem where the focus is on
using the auxiliary domains to help improve the regres-
sion performance of a target class. To the best of our
knowledge, our work is one of the first to apply the multi-
task learning model for siRNA efficacy analysis for learn-
ing regression models.
To test our multi-task regression learning framework,
extensive experiments were conducted to show that
multi-task learning is naturally suitable for cross-plat-
form siRNA efficacy prediction. The biological features
were ranked to derive the most important common fea-
tures for siRNA design across different experiments on
this model. Furthermore, our experiments also validate
the observation that the siRNA efficacy depends on the
properties of the targeted mRNA, instead of merely on
the properties of siRNA sequence. We also conjecture
that continued computational siRNA efficacy study can
be benefited greatly from the multi-task learning frame-
work by focusing on a much smaller task level, where we
can take, for example, each mRNA and its binding siR-
NAs as a task, rather than an entire experiment as a task.
Methods
Data source
Our study was performed on the siRNA efficacy dataset
compiled by Shabalina et al., which contains 653 19-nt
siRNAs targeted on 52 genes (no homology genes
between them) from 14 cross-platform experiments [23].
The general description of this data source is given in
Table 1, from which we can see that different experiments
actually have different output label spaces in the evalua-
tion of siRNA efficacy. It is reported that this is a mixture
set of dataset including a broad range of siRNA concen-
trations, which, in distribution, is substantially biased
towards the high end (over 300 siRNAs tested at 100 nMLiu et al. BMC Bioinformatics 2010, 11:181
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concentrations) in the evaluation of siRNA efficacy. The
diversity in the data explains partly why the different
measurement errors are non-trivial [23] [Additional file
1]. In addition, another two experiments with 32 siRNAs
targeting on 10 distinct mRNAs are included in our study
as two independent test sets [23]. The siRNA efficacy in
these experiments was tested at very low concentrations
to show that the effectiveness of our multi-task learning
paradigm for predicting the efficacy of siRNAs is inde-
pendent on concentrations.
I n  o u r  s t u d y ,  t h e  s a m e  1 9  p a r a m e t e r  v a l u e s  w e r e
adopted for siRNA efficacy prediction as presented by
Shabalina et al. [23] (see Table 2), since these parameters
have covered most of the reported features that are signif-
icantly correlated with siRNA efficacy so far, such as
nucleotide content of G, nucleotide content of U and
position-dependent nucleotide etc. Under our multi-task
Table 1: Description of the 14 cross-platform RNAi experiments as well as another 2 independent experiments performed 
at low siRNA concentrations. 
Experiments #mRNA #siRNA Platform label scale (min-max)
E1 2 179 4.0-127.8
E2 2 67 22.0-118.8
E3 1 14 2-52
E4 10 50 1.0-115.7
E5 2 12 18-110
E6 4 50 5.8-124.4
E7 3 19 20-127
E8 21 103 16.0-100.0
E9 1 34 1.5-93.9
E10 1 6 32-77
E11 2 24 5-120
E12 2 20 11.4-76.4
E13 1 5 0-34
E14 3 40 14-110
IE1 6 20 1.56-100
IE2 4 12 1-80
"E" denotes "Experiment";"IE" denotes "Independent experiment".Liu et al. BMC Bioinformatics 2010, 11:181
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learning paradigm, a quantitative evaluation of these 19
features will be provided to reveal the relevance of these
19 features to siRNA design, as shown in the next section.
We should explain the reasons for why this particular
data source is chosen: First, the data source contains
nearly all the RNAi experiments with numerical siRNA
efficacy values reported in recent studies, thus proven to
be a complete dataset for training regression models for
siRNA efficacy prediction. Second, the data source is a
mixture dataset with cross-platform experiments stated
in P?l Sæ trom dataset, a dataset misused by several com-
putational siRNA efficacy prediction models where its
data diversity is not considered [30,31]. We want to use
the multi-task learning paradigm to address this cross-
platform issue by comparing our test results with those of
traditional studies. We noted that in the current study, we
only focused on the regression model rather than the
general classification models, since the siRNA efficacy
values are in nature continuously valued under different
experimental platforms and we don't want to waste any
data information in using our model. Though our model
is designed for regression problem, it's actually also suit-
able for the classification problem with categorical data as
input. To support our argument, we applied our model in
multi-task classification with the siRecords dataset [22],
which normally standardized siRNA with consistent effi-
cacy ratings across different platforms. The results are
listed in the supplementary materials [Additional file 1],
and they also indicate that our multi-task classification
model is significantly better the single-task classification
models.
Linear ridge regression model
Given a representation of siRNAs as feature vectors, a lin-
ear ridge regression model was applied [35] to predict the
novel siRNA efficacy from a set of siRNAs with known
efficacy. Linear ridge regression is a classical statistical
technique that aims to find a linear function that models
the dependencies between covariances   in d and
response variables   in , where d is the number of
data features. The standard way to handle this problem is
using the ordinary least square (OLS) method, which
minimizes the squared loss:
However, due to limited training examples, the variance
of the estimated w by OLS may be large, and thus the esti-
mation is not reliable. An effective way to overcome this
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Table 2: Feature weights for siRNA design derived from multi-task learning
No. Feature Weight
1 position-dependent nucleotide consensus: sum 0.1954
2 Δ G difference between positions 1 and 18 0.0987
3 Δ G of sense-antisense siRNA duplexes 0.0774
4 position-dependent nucleotide consensus: preferred 0.0733
5 preferred dinucleotide content index 0.0726
6 local target mRNA stabilities (Δ G) 0.0651
7 position-dependent nucleotide consensus: avoided 0.0640
8 nucleotide content: U 0.0603
9 stability (Δ G) of dimers of siRNAs antisense strands 0.0537
10 stability profile for each two neighboring base pairs in the siRNA sense-antisense in position 1 0.0384
11 siRNA antisense strand intra-molecular structure stability (Δ G) 0.0327
12 avoid dinucleotide content index 0.0324
13 stability profile for each two neighboring base pairs in the siRNA sense-antisense in position 13 0.0298
14 stability profile for each two neighboring base pairs in the siRNA sense-antisense in position 18 0.0279
15 nucleotide content: G 0.0267
16 stability profile for each two neighboring base pairs in the siRNA sense-antisense in position 2 0.0222
17 stability profile for each two neighboring base pairs in the siRNA sense-antisense in position 6 0.0159
18 stability profile for each two neighboring base pairs in the siRNA sense-antisense in position 14 0.0138
19 frequency of potential targets for siRNA 0.0000Liu et al. BMC Bioinformatics 2010, 11:181
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problem is to penalize the norm of w as in ridge regres-
sion. Instead of minimizing squared errors, ridge regres-
sion minimizes the following cost:
where λ is a fixed positive number. By introducing the
regularization parameter λ, the ridge regression can
reduce the estimated variance at the expense of increas-
ing training errors. The regularization parameter λ con-
trols the trade-off between the bias and variance of the
estimate. In the linear ridge regression model, it is shown
that the predicted label (i.e., wT x) of a new unlabeled
example x is:
where K is the matrix of dot products of the vectors {xi,
i = 1,2, ..., n} in the training set:
and κ is the vector of dot products of x and the vectors
in the training set:
It should be noted that this model could be generalized
to kernel ridge regression by using the kernel trick [36].
However, model selection is not our main focus here.
Various regression models can be applied, but we choose
the linear ridge regression as our regression model based
on the following reasons: (1) The performance of linear
ridge regression model is comparable to most of the
state-of-art regression models on siRNA efficacy predic-
tion, and it is simple enough in representation [29]. We
applied the sophisticated support vector regression (SVR)
with both linear kernel and radial basis function kernel in
siRNA efficacy prediction, and we obtained nearly the
same (even worse) prediction results as compared to lin-
ear ridge regression (See Results and Discussion). (2) We
also want to exploit the feature importance across the
platforms for better siRNA design. This goal cannot be
achieved if we use a kernel regression model since it will
map the input features as some non-meaningful high-
dimensional representations.
In our experimental study, 5-fold cross-validation was
applied to find the optimal regularization parameter that
minimizes the cross-validation errors. For all the 14
experiments, 5-fold cross-validation is performed on 5
regularization parameter regions respectively, i.e.
[0.001,0.1] with interval 0.001, [0.01,0.1] with interval
0.01, [0.1,1] with interval 0.1, [1,10] with interval 1 and
[10,100] with interval 10. Finally λ = 10 was obtained by
evaluation of the total cross-validation errors in the 14
experiments. This parameter was kept the same through-
out our study for consistent comparison.
Performance Measurement
In our experiments, the proposed multi-task learning and
traditional single task learning were evaluated based on
root mean squared error (RMSE) [35], which is usually
used as a measurement of the prediction ability in the
regression model. The residual e  is the difference
between the observed data and the fitted model, denoted
as:
where yi is the observed siRNA efficacy and   is the
predicted siRNA efficacy. The root mean squared error is
defined as follows:
where n is the number of predicted siRNA sequences.
The smaller the RMSE is, the better the predict perfor-
mance is.
Paired t-test for model comparison
In our study, the paired t-test and F-test is performed to
compare multi-task learning versus single-task learning
in siRNA efficacy prediction [37]. Paired t-test is proven
to work well by machine learning community in measur-
ing the significance of one model outperforming another
model and it is suitable for the most common data distri-
bution assumption (say, normal distribution, instead of
specific chi-squared distribution, for example) when we
don't know the exact data distribution. To be briefly, this
test is trying to determine whether the mean of a set of
samples, i.e., the cross-validation estimates for the vari-
ous datasets (tasks) is significantly greater than, or signif-
icantly less than the mean of another, followed by the
assumptions that the observed data are from a matched
subject and are drawn from a population with nearly to
normal distribution.
More specifically, given two paired sets Xi and Yi of n
measured values, which could be the error rates evalu-
ated by RMSE for each experiments under the single-task
learning model and multi-task learning model in out
study, the paired t-test determines whether this two
model differ from each other in a significant way under
the assumptions that the paired prediction error rate dif-
ferences for each experiment are independent and identi-
cally normally distributed.
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To apply the paired t-test, let:
Then define t by:
where n- 1 is the statistic degrees of freedom. Once a t
value is determined, a p-value can be found using a table
of values from Student's t-distribution to determine the
significance level at which two models differ.
Multi-task learning for siRNA efficacy prediction
Computational framework
Multi-task learning has been developed in machine
learning research to situations where multiple related
learning tasks are accomplished together [38-46]. It has
been proven to be more effective than learning each task
independently when there are explicit or hidden inter-
relationship among the tasks that can be exploited [47].
The intuition underlying the framework is that the multi-
ple related tasks can benefit each other by sharing the
data and features across the tasks, which can often boost
the learning performance of each single task. Such an
advantage is especially evident when the number of
labeled data in each task is limited, such that training on
each single task with insufficient labeled data may not
work well. Recently, researchers have begun to resort to
the multi-task learning model to solve biological prob-
lems, such as medical diagnosis, tumor classification and
drug screening [48-50]. However, applications of multi-
task learning in bioinformatics have just begun.
In this study, a comprehensive computational frame-
work for cross-platform RNAi experiment analysis is pre-
sented. The workfellow of the framework is shown in
Figure 1. Extensive experimental tests were conducted to
thoroughly examine the performance of the multi-task
learning framework.
Algorithm
I n  t h i s  s e c t i o n ,  w e  d e m o n s t r a t e  h o w  t o  f o r m u l a t e  t h e
cross-platform siRNA efficacy prediction problem as a
multi-task learning problem. A critical issue is to learn a
set of sparse (regression) functions across the tasks. In
particular, l1-norm regularization is used to control the
number of learned features common for all the tasks, and
the whole multi-task learning problem is equivalent to a
convex optimization problem [47]. Consequently, the
problem is solved iteratively until convergence, by alter-
nately performing an unsupervised step and a supervised
step. In the unsupervised step, the common representa-
tions shared by the tasks are learned and then in the
supervised step, these representations are used to learn
the regression functions for each each task. Detailed algo-
rithm derivations can be found in supplementary file
[Additional file 1]. A Matlab script package for such
multi-task learning in siRNA efficacy prediction is pro-
vided, which is accessible freely on our website.
Feature selection across tasks
In this section, we show that the proposed multi-task
learning provides us an efficient way to evaluate the fea-
ture importance in siRNA design across various plat-
forms. Based on the parameter W that are derived from
Equation (11), the optimal solution for matrix D  is
obtained, which can be used for feature selection. In our
case, D is a diagonal matrix with D = diag [λ1, ..., λd], since
U is defined as an identity matrix. Specifically, we have
If λi ≠ 0, the ith feature is the common feature; other-
wise, the ith feature is not useful in regression learning
across the different tasks, since its regression weights are
zeros for all the tasks. The value of λi indicates the weight
of the corresponding feature, which gives us a quantita-
tive way to evaluate the importance of various features for
siRNA design.
Results and Discussion
In this section, a number of experiments on multi-task
learning for cross-platform siRNA efficacy prediction are
performed. The siRNA efficacy prediction problem is for-
mulated as a linear ridge regression model and the
parameters of this model are tuned with a 5-fold cross-
validation process. The root mean square error (RMSE) is
adopted as the performance evaluation for different test
results. To verify the statistical significance of our model
over the baseline algorithms, the paired t-test on the
experimental results is also conducted [37].
Multi-task learning for cross-platform siRNA efficacy 
prediction
STUDY 1: Single task learning
In this study, linear ridge regression was we first com-
pared with SVR for single task siRNA efficacy prediction.
As an overview, linear ridge regression was shown to
achieve the same prediction results as SVR (see Table 3).
As a result, linear ridge regression was taken as the cho-
sen learning method in the following study. We show that
the 14 cross-platform experiments that we use are indeed
have different conditional distribution. We will see that
simple combinational or normalization methods only
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provide very limited  gain on the improvement of final
siRNA efficacy prediction.
In our first test scenario (Test 1), we randomly selected
50% of the data from each experiment(or platform) as the
training data to train a linear ridge regression model, and
then tested it on the remaining 50% of the data in that
experiment. We ran the test 10 times and reported the
average RMSE for each experiment. The result of Test 1
was compared with another test scenario (Test 2), in
which the same parameters are used under normalization
process. In the normalization process, we scaled all the
experimental labels (siRNA efficacy values) into [0,1] and
pooled 50% of the data from each experiment together to
train a general model. Finally, we tested the model on the
remaining 50% of the data for each experiment, respec-
tively. The final RMSE was calculated based on the re-
scaled predicted and ground-truth labels. Results of these
two tests are given in Table 4.
From Table 4, we can clearly see that even if the training
data labels are scaled to the same level, and the training
data are pooled together to train a general model for indi-
vidual task prediction, the prediction results are still not
Figure 1 Computational framework in our study.Liu et al. BMC Bioinformatics 2010, 11:181
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Page 8 of 16
improving all the time. In fact, we observe worse results
in half of the experiments under this general model. Sta-
tistical test evaluation on these two models has shown
that there is no statistically significant difference between
these two prediction results (p-value = 0.7043). It indi-
cates that directly scaling the labels and increasing the
number of training data by combining the data from
cross-platform experiments only provides limited help in
improving the prediction performance; in many cases the
performance is degraded. All tests so far reveal that there
exists a high-level of diversity across these 14 experi-
ments, which motivates us to apply more sophisticated
multi-task learning in this study.
STUDY 2: Multi-task learning
In this study, we show that multi-task learning is able to
improve the prediction performance as compared to sin-
gle-task learning. Multi-task learning is performed on the
14 cross-platform experiments with the same setting as
Test 1 (50% training data as well as 50% testing data for
each experiment). Furthermore, in order to examine the
impact of the size of training set on the model's perfor-
mance, we compared single task learning with multi-task
learning trained with other different percentages of data
from each experiment. That is, we trained the models
with 10%, 30%, 70% and 90% of the whole data, respec-
tively. The testing results are summarized in Table 4 and
Figure 2 as Test 3.
F r o m  T a b l e  5 ,  i t  c a n  b e  c l e a r l y  s e e n  t h a t  m u l t i - t a s k
learning achieves better performance as compared to sin-
gle task learning under various training data percentages
for nearly all the experiments. An exception is for experi-
ment 9, in which the two models obtained almost the
same level of performance. Pair t-test evaluation indi-
cated that multi-task learning is significantly superior to
single task learning in siRNA efficacy prediction with all
different percentages of training data (p-values are listed
in Table 5), thanks to the joint learning strategy employed
in the multi-task learning model. The prediction perfor-
mance of most experiments is shown to be correlated to
the size of training data, both for single task learning and
for multi-task learning, as shown in Figure 2.
STUDY 3: Testing on independent experiments
Another two experiments [23] were also used as indepen-
dent experiments in this study (Table 1). These experi-
ments were tested in a very low siRNA concentration,
including 6 mRNAs with 20 binding siRNAs and 4
mRNAs with 12 binding siRNAs, respectively. Two differ-
ent tests were performed: (1) Single task learning was
compared with multi-task learning on these two indepen-
dent experiments (Test 4), and (2) Multi-task learning
was performed on the two independent experiments
together with the former 14 experiments, with a total of
16 experiments (Test 5). Each test kept 50% of the data as
a training set as well as 50% of the data as a testing set for
each experiment. The average over 10 RMSEs was com-
pared specifically on two independent experiments under
two test scenarios. The goal of these tests is to examine
the influence of newly added tasks on the existing tasks
under our multi-task learning model, and these newly
added tasks may be generated in very different experi-
mental conditions. Detailed test results are summarized
in Table 6.
We make some observations from the results in Table 6:
(1) Multi-task learning gives better performance as com-
Table 3: Comparison between linear ridge regression and support vector regression for single task siRNA efficacy 
prediction. 
Test RMSE
T1 T2 T3 T4 T5 T6 T7
Linear ridge regression 23.5544 23.0751 12.8477 30.2501 27.8395 32.8025 32.9677
SVR with linear kernel 23.6965 22.1477 13.3903 31.9928 26.1998 32.8823 32.2824
SVR with radial basis function kernel 29.6775 24.4753 13.5664 31.1238 37.2164 36.2681 43.4349
T8 T9 T10 T11 T12 T13 T14
Linear ridge regression 26.5710 13.6068 13.4394 36.9945 33.6679 17.3333 28.7044
SVR with linear kernel 27.0521 15.2284 25.9767 34.9588 32.8858 19.9620 30.7536
SVR with radial basis function kernel 25.6995 43.3165 25.9767 32.9811 26.6623 19.9620 25.8301
"E" denotes "Experiment". Linear ridge regression and support vector regression(with linear kernel and radial basis function kernel) are 
trained with 50% of the data from each experiment, respectively. p-value calculated by pair t-test on linear ridge regression and SVR with 
linear kernel is 0.2592. p-value calculated by pair t-test on linear ridge regression and SVR with radial basis function kernel is 0.0913.Liu et al. BMC Bioinformatics 2010, 11:181
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pared to single-task learning for the two independent
experiments in the siRNA efficacy prediction, and (2)
Multi-task learning with more tasks proved to be more
helpful for siRNA efficacy prediction, as shown in Test 5.
(3) The multi-task regression generalized well to new
experimental conditions (and new mRNAs) of the two
independent experiments. These conclusions indicate
that multi-task learning provides an effective way to alle-
viate the data insufficiency problem of single task
domains by exploiting the available synergy between dif-
ferent tasks. More tasks are expected to provide much
more help from a joint learning procedure. Furthermore,
with more tasks, multi-task learning can help more to
improve the in-silico siRNA design targeted on new
mRNAs.
Ranking features for cross platform siRNA efficacy prediction
Using our multi-task learning model, we compute the
weights for each selected feature in the siRNA efficacy
prediction across 14 cross-platform experiments, by con-
sidering the learned diagonal matrix D  calculated in
Equation (11). Multi-task learning in this case is also
trained with 50% of the data for each experiment and ran-
domly performed by 10 times. The features ranked with
their weights are listed in order in Table 2. It can be seen
that the position-dependent nucleotide consensus fea-
tures and Δ G difference between positions 1 and 18 con-
tribute greatly to the design of efficient siRNAs. This
conclusion is consistent with the study on the siRNA
design as reported in recent works [51,52]. In addition,
we can see that the feature of local target mRNA stability
has a relatively high weight (0.07) in determining the
siRNA efficacy, and this indicates that the properties of
mRNA cannot be ignored in the design of potent siRNAs.
We will further discuss this issue in the following section.
Hypothesis: shall we treat task in an "mRNA"-level ?
The impact of mRNA properties (especially the second-
ary structure of mRNA) on the siRNA binding efficacy
has long been a controversial issue [24,52-54]. Traditional
studies suggested that it may not be critical to consider
the target site's secondary structure in siRNA efficacy
prediction. Several models have been presented based on
the features merely derived from siRNA sequences to
predict their efficacies [18,24]. They show that the mRNA
characteristics seem to offer little to the predictive
strength of their models. On the other hand, several stud-
ies have shown that the properties of mRNA may play an
important role in determining the binding efficacy of a
siRNA [25,55-57]. These reports motivate us to study the
impact of mRNA properties on siRNA binding efficacy
from a multi-task learning perspective.
We examine the possibility for siRNA efficacy predic-
tion from a smaller multi-task level, i.e., we consider the
task at "mRNA" level instead of the "experiment" level in
the efficacy prediction. If the properties of mRNA influ-
ence siRNA efficacy, siRNAs that bind to the same
mRNA should have some potential connections and thus
be viewed as a task in the multi-task learning model. For
example, it has been reported that sequence length of tar-
get mRNA has certain positive correlation with the activ-
ity of binding siRNAs [11]. We speculate that there
should exist certain efficacy distribution diversity across
siRNAs binding to different mRNAs while this efficacy
distribution diversity should be weak within the siRNAs
binding to the same mRNAs. Similar to the tests per-
formed on multiple experiments, combining siRNAs tar-
geted on different mRNAs may not benefit the final
prediction results. If this is the case, it could be computa-
tionally validated that the properties of mRNA indeed
have an important impact on the siRNA design.
Table 4: Single task learning with direct combination and label scaling for siRNA efficacy prediction. 
Test RMSE
T1 T2 T3 T4 T5 T6 T7
Test 1 23.5500 23.0800 12.8500 30.2500 27.8400 32.8000 32.9700
Test 2 24.9500 29.8900 31.2700 26.8300 32.1900 29.5200 29.2500
T8 T9 T10 T11 T12 T13 T14
Test 1 26.5700 13.6100 13.4400 36.9900 33.6700 17.3300 28.7000
Test 2 27.2600 15.8700 12.3700 26.2400 30.3800 21.4700 25.9700
"E" denotes "Experiment". Test 1: Selected 50% of the data from each experiment to train a regression model, and tested the model on the 
remain 50% of the data of each experiment, respectively. Test 2: Scaled all the experimental labels into [0,1] and pooling together 50% of the 
data from each experiment to train a general model, and tested the model on the remain 50% of the data of each experiment, respectively. 
p-value calculated by pair t-test on Test 1 and Test 2 is 0.7043.Liu et al. BMC Bioinformatics 2010, 11:181
http://www.biomedcentral.com/1471-2105/11/181
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Figure 2 Comparison between multi-task learning and single task learning for siRNA efficacy prediction. Each model is trained with 10%, 30%, 
50%, 70% and 90% of the data from each experiment, respectively. STL:Single task learning. MTL: Multi-task learning. RMSE: Root mean square error.Liu et al. BMC Bioinformatics 2010, 11:181
http://www.biomedcentral.com/1471-2105/11/181
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In order to validate this hypothesis, we performed tests
on our siRNA data by grouping the siRNAs binding to 55
mRNAs as 55 tasks. Among them, 20 mRNAs with their
number of binding siRNAs in the experiments larger than
5 were selected, and those mRNAs with a very small
number of binding siRNAs were removed as they have
too few instances to be viewed as a task. Our final dataset
includes 20 mRNAs/tasks with a total of 482 siRNA
sequences binding to them. A Detailed description of this
dataset is given in Table 7.
Similar studies like Test 1 - Test 3 were performed on
this dataset, by viewing each mRNA and its binding siR-
NAs as a task. The new tests are denoted as Test 6 - Test 8
and summarized in Table 8. Table 8 shows that when the
tasks were considered in a smaller "mRNA"-level, direct
combination and scaling data label still provide limited
help on the improvement of the prediction performance
(p-value calculated by pair t-test was 0.5862). This indi-
cates that there exists certain efficacy distribution diver-
sity between different tasks. As expected, multi-task
learning was superior to single task learning in 17 out of
20 tasks (p-value calculated by pair t-test was 0.0033).
W e  a lso  designed a  t est  t o fu rt he r e xam in e t he  da ta
characteristics of the siRNAs within one single task. The
motivation of this test was discussed previously: since we
hypothesized that there exists certain efficacy distribu-
tion diversity across different mRNAs/tasks in the siRNA
efficacy prediction, little diversity should exist within the
task. In this test, two tasks with a large number of siRNA
instances were selected as the datasets (Task 1 and Task 2
with 89 and 90 siRNAs respectively). These two datasets
(denoted as D1 and D2) are randomly split into 5 sub-
tasks and similarly studied as Test 1 - Test 2 are per-
formed on them respectively. Such a study is denoted as
Test 9 and summarized in Table 9. It should be noted that
for each dataset, since it is selected as a single mRNA
with its binding siRNAs, there should be little data distri-
bution diversity across the 5 sub-tasks. As shown in Table
9, the data combination and label scaling really work for
two datasets in the improvement of efficacy prediction at
this time. This is explained by saying that all siRNAs
binding to one mRNA are actually homogenous in
nature. The prediction performance can thus be
improved by increasing the number of homogenous
training data.
In conclusion, in siRNA efficacy prediction, there
indeed exists certain efficacy distribution diversity across
the siRNAs binding to different mRNAs, and this distri-
Table 5: Comparison between multi-task learning and single task learning for siRNA efficacy prediction. 
Test 3 RMSE
Single task learning Multi-task learning
10% 30% 50% 70% 90% 10% 30% 50% 70% 90%
E1 28.3515 24.1538 23.5544 22.8080 23.4952 27.6417 24.0150 23.5313 22.7155 23.4194
E2 28.1353 24.7949 23.0751 21.6717 20.5756 25.4531 22.0457 21.1488 20.6969 20.5423
E3 14.1021 12.7868 12.8477 12.8390 11.2925 12.4403 11.5239 11.2708 11.0255 10.0032
E4 36.7345 32.4953 30.2501 28.5389 25.5934 31.6222 27.8789 27.9831 27.5373 27.2947
E5 37.7847 31.7246 27.8395 27.2221 32.1410 37.6029 27.5771 24.0499 23.5798 24.7571
E6 37.9884 36.6409 32.8025 31.0090 27.0574 34.9948 31.9597 30.0650 28.7117 24.6019
E7 46.1408 40.6899 32.9677 34.0303 29.4516 45.3279 34.8915 30.3053 29.9185 27.0738
E8 29.4008 27.4798 26.5710 24.8380 26.7436 26.5423 24.6162 24.4261 23.7297 24.9686
E9 31.9814 15.5796 13.6068 13.8639 12.2373 35.7421 19.8070 17.2665 16.2435 13.3189
E10 56.8917 19.3907 13.4394 12.8776 11.4408 56.8917 19.1463 12.9610 12.2792 11.2242
E11 40.4318 37.2323 36.9945 34.1775 32.1200 38.9771 31.7360 31.0361 29.2156 28.6740
E12 30.7272 29.4070 33.6679 35.2603 24.8004 29.4405 24.4063 24.4616 24.8690 22.1497
E13 18.8997 18.0514 17.3333 14.1208 13.5105 18.8997 17.5524 16.4534 13.1908 10.9338
E14 34.8579 33.0815 28.7044 25.9012 25.7859 30.0917 27.8195 25.3132 24.3546 24.6832
"E" denotes "Experiment". Test 3: Comparison between multi-task learning and single task learning for siRNA efficacy prediction, both trained 
with 10%, 30%, 50%, 70% and 90% of the data from each experiment, respectively. p-values calculated by pair t-test on multi-task learning 
and single task learning with different percentages of training data: 0.0268(10%); 0.0046(30%); 0.0093(50%); 0.0151(70%); 0.0389(90%).Liu et al. BMC Bioinformatics 2010, 11:181
http://www.biomedcentral.com/1471-2105/11/181
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bution diversity seems to be weak within  the siRNAs
binding to the same mRNAs. This result helps validate
the observation that the properties of mRNA indeed have
influence on potent siRNA design, since certain data het-
erogeneity has been detected across the siRNAs binding
to different mRNAs.
Conclusions
In this study , a multi-task learning paradigm for cross-
platform siRNA efficacy prediction is presented. Exten-
sive empirical tests have been conducted to demonstrate
that multi-task learning provides an efficient way for the
alleviation of data heterogeneity and insufficiency across
multiple tasks. Our method was shown to achieve better
prediction performance as compared to the traditional
regression models on each individual task independently.
This paradigm facilitates different tasks used to learn the
hidden data patterns based on a common feature repre-
sentation. In addition, our experiments validated that
siRNA efficacy not only depends on the properties of
siRNA, but also on the properties of its targeted mRNA.
Future research on siRNA design could be done to
address the data heterogeneity issue further under the
multi-task learning scheme. One approach is by taking
each mRNA and its binding siRNAs as a task rather than
taking each experiment as a task. Another important
consideration is to address the issue on finding the major
causes for such heterogeneity across different experimen-
tal conditions or mRNAs. Our multi-task learning para-
d i g m  c a n  o n l y  r e v e a l  s u c h  h e t e r o g e n e i t y .  F o r
experimental conditions, we wish to further find out what
is important on the siRNA concentration, the knockdown
assay, etc., in the siRNA design. Similarly, and more
importantly, we wish to pursue the question of identify-
ing the most important characteristics that determine the
siRNA binding efficacy. Addressing these issues would
help to shed new light on why certain genes seem to be
e a s i e r  t o  b e  k n o c k e d  d o w n  b y  R N A i  t h a n  o t h e r s .  W e
believe that a better understanding to such problems can
be achieved when the amount of available data increases
and more new features that influence siRNA-mediated
RNA interference are identified.
Availability
A package of matlab scripts for cross-platform siRNA
efficacy prediction under the proposed multi-task learn-
ing paradigm is presented. This package together with
the datasets used in our manuscript is freely accessible at
http://lifecenter.sgst.cn/RNAi/.
Appendix - Experimental setting for tests 
performed in our study
Test 1 : For 14 cross-platform experiments as 14 individ-
ual tasks, selected 50% of the data from each experiment
to train a regression model, and tested the model on the
remain 50% of the data of each experiment, respectively.
Test 2 : For 14 cross-platform experiments as 14 indi-
vidual tasks, scaled all the experimental labels into [0,1]
and pooling together 50% of the data from each experi-
ment to train a general model, and tested the model on
the remain 50% of the data of each experiment, respec-
tively.
Test 3 : For 14 cross-platform experiments as 14 indi-
vidual tasks, perform comparison between multi-task
learning and single task learning for siRNA efficacy pre-
diction, both trained with 10%, 30%, 50%, 70% and 90% of
the data from each experiment, respectively.
Test 4 : For 2 independent experiments, perform com-
parison between single task learning and multi-task
learning on them, both trained with 50% of the data from
each experiment, respectively.
Test 5 : Multi-task learning on the two independent
experiments together with the former 14 experiments,
Table 6: Tests on two independent experiments. 
Tests RMSE
IE1 IE2
Test 4 (50% training data) Single task learning 34.1116 35.8600
Multi-task learning 29.7394 30.5459
Test 5 (with added tasks, 50% training data) 26.6910 26.1009
"E" denotes "Experiment". Test 4: Comparison between single task learning and multi-task learning on the two independent experiments, 
both trained with 50% of the data from each experiment, respectively. Test 5: Multi-task learning on the two independent experiments 
together with the former 14 experiments, totally 16 experiments, trained with 50% of the data from each experiment, respectively.Liu et al. BMC Bioinformatics 2010, 11:181
http://www.biomedcentral.com/1471-2105/11/181
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Table 7: Description of the RNAi dataset with viewing each mRNA and its binding siRNAs as a task. 
Tasks #mRNA #siRNA
T1 M60857 89
T2 U47298 90
T3 J03132 38
T4 U92436 29
T5 LaminA 44
T6 M16553 8
T7 NM_031313 11
T8 NM_020548 9
T9 X75932 10
T10 NM_002046 20
T11 M26071 10
T12 U47298 34
T13 M16553 6
T14 NM_001315 8
T15 NM_000875 16
T16 M25346 8
T17 AF493916 10
T18 AK122643 14
T19 NM_144586 14
T20 M33197 12
"T" denotes "Task".Liu et al. BMC Bioinformatics 2010, 11:181
http://www.biomedcentral.com/1471-2105/11/181
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totally 16 experiments, trained with 50% of the data from
each experiment, respectively.
Test 6 : For the 20 tasks in a "mRNA" level, selected 50%
of the data from each experiment to train a regression
model, and tested the model on the remain 50% of the
data of each experiment, respectively.
Test 7 : For the 20 tasks in a "mRNA" level, scaled all the
experimental labels into [0,1] and pooling together 50% of
the data from each experiment to train a general model,
and tested the model on the remain 50% of the data of
each experiment, respectively.
Test 8 : For the 20 tasks in a "mRNA" level, perform
multi-task learning for siRNA efficacy prediction, trained
with 50% of the data from each experiment, respectively.
Test 9 : Two datasets (D1 and D2) with siRNAs binding
to single mRNA are randomly split into 5 sub-tasks and
similar study as Test 1-Test 2 are performed on them
respectively.
Additional material
Additional file 1 Supplementary materials for the manuscript. This file 
contains detailed explanation of multi-task learning algorithm, together 
with the description of the data used in our study
Table 9: Test on the efficacy prediction with siRNAs binding to single mRNA. 
Test 9 RMSE
Task 1 Task 2 Task 3 Task 4 Task 5
STL 21.7139 31.3104 22.0464 20.5358 31.3807
D1 STL with combination and scaling 20.8203 24.7029 21.2602 18.7345 28.9061
STL 32.3753 28.3268 27.7405 22.1219 33.1770
D2 STL with combination and scaling 26.9951 25.7676 25.0711 19.9418 32.4254
"T" denotes"Task". STL: single task learning. Test 9: Two datasets (D1 and D2) are randomly split into 5 sub-tasks and similar study as Test 1-
Test 2 are performed on them respectively.
Table 8: Comparison between multi-task learning and single task learning in a "mRNA" task level. 
Test RMSE
T1 T2 T3 T4 T5 T6 T7 T8 T9 T10
Test 6 22.9156 29.7953 24.4563 20.2755 13.6265 25.5433 28.6792 28.6911 13.8089 47.9704
Test 7 22.0309 28.8772 34.4272 22.4800 29.5645 22.3986 23.4719 42.3385 16.1072 34.2505
Test 8 22.2569 29.4852 22.9905 19.1120 11.7851 23.5123 29.9718 28.4760 11.7036 37.8482
T11 T12 T13 T14 T15 T16 T17 T18 T19 T20
Test 6 43.6353 13.9306 14.4649 5.6649 35.8113 33.6464 29.6981 29.4559 30.2422 21.0494
Test 7 35.4975 16.8432 13.0795 25.0440 26.3289 36.5158 29.9756 27.0347 26.0495 21.7607
Test 8 41.2163 18.2205 13.6913 5.7872 27.3318 27.5945 23.6955 26.5286 24.3853 16.2990
"T" denotes "Task". Test 6: Selected 50% of the data from each experiment to train a regression model, and tested the model on the remain 
50% of the data of each experiment, respectively. Test 7: Scaled all the experimental labels into [0,1] and pooling together 50% of the data 
from each experiment to train a general model, and tested the model on the remain 50% of the data of each experiment, respectively. Test 
8: Multi-task learning for siRNA efficacy prediction, trained with 50% of the data from each experiment, respectively. p-value calculated by 
pair t-test on Test 6 and Test 7 is 0.5900. p-value calculated by pair t-test on Test 6 and Test 8 is 0.0033.Liu et al. BMC Bioinformatics 2010, 11:181
http://www.biomedcentral.com/1471-2105/11/181
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